Md. Code, Insurance § 27-909.1
This is the official text of Md. Code, Insurance § 27-909.1, part of Maryland’s Code, Insurance — regulates insurance companies and the policies they sell.
Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.
§27–909.
Official statutory text
§27–909.1.
(a) (1) In this section the following words have the meanings indicated.
(2) “Genetic test” means an analysis of human DNA, RNA, chromosomes, proteins, or metabolites that detects genotypes, mutations, or chromosomal changes.
(3) “Insurance carrier” means a company authorized to sell insurance policies in the State.
(b) (1) This section applies only to life insurance and disability insurance policies or contracts.
(2) This section does not prohibit an insurance carrier that offers, issues, or delivers a life insurance or disability insurance policy or contract in the State from:
(i) accessing an applicant’s medical record as part of the application process; or
(ii) considering a medical diagnosis included in an individual’s medical record, even if the diagnosis was based on the results of a genetic test.
(c) (1) Except as provided in paragraph (2) of this subsection and subject to paragraph (3) of this subsection, an insurance carrier that offers, issues, or delivers a life insurance or disability insurance policy or contract in the State may not unfairly discriminate against an individual by conditioning insurance rates, the provision or renewal of insurance coverage, or other conditions of insurance based on medical information, including the results of a genetic test for which there is not a relationship between the medical information and the cost of the insurance risk that the insurer would assume by insuring the applicant.
(2) In demonstrating the relationship described in paragraph (1) of this subsection, the insurer may rely on actuarially sound principles or actual or reasonably anticipated experience.
(3) An insurance carrier that offers, issues, or delivers a life insurance or disability insurance policy or contract in the State may not:
(i) access sensitive medical information, including the genetic data of an individual, without first obtaining the individual’s signed, written consent; or
(ii) mandate existing or new genetic testing or full genome sequencing as a prerequisite for life insurance or disability insurance eligibility or coverage.
(4) The insurance carrier, applicant, or policy or contract holder may not waive the provisions of paragraph (3)(ii) of this subsection under any circumstances.
(d) The Commissioner may issue an order under §§ 4–113 and 4–114 of this article or §§ 27–501 and 27–505 of this title if the Commissioner finds a violation of this section.
(a) (1) In this section the following words have the meanings indicated.
(2) “Genetic test” means an analysis of human DNA, RNA, chromosomes, proteins, or metabolites that detects genotypes, mutations, or chromosomal changes.
(3) “Insurance carrier” means a company authorized to sell insurance policies in the State.
(b) (1) This section applies only to life insurance and disability insurance policies or contracts.
(2) This section does not prohibit an insurance carrier that offers, issues, or delivers a life insurance or disability insurance policy or contract in the State from:
(i) accessing an applicant’s medical record as part of the application process; or
(ii) considering a medical diagnosis included in an individual’s medical record, even if the diagnosis was based on the results of a genetic test.
(c) (1) Except as provided in paragraph (2) of this subsection and subject to paragraph (3) of this subsection, an insurance carrier that offers, issues, or delivers a life insurance or disability insurance policy or contract in the State may not unfairly discriminate against an individual by conditioning insurance rates, the provision or renewal of insurance coverage, or other conditions of insurance based on medical information, including the results of a genetic test for which there is not a relationship between the medical information and the cost of the insurance risk that the insurer would assume by insuring the applicant.
(2) In demonstrating the relationship described in paragraph (1) of this subsection, the insurer may rely on actuarially sound principles or actual or reasonably anticipated experience.
(3) An insurance carrier that offers, issues, or delivers a life insurance or disability insurance policy or contract in the State may not:
(i) access sensitive medical information, including the genetic data of an individual, without first obtaining the individual’s signed, written consent; or
(ii) mandate existing or new genetic testing or full genome sequencing as a prerequisite for life insurance or disability insurance eligibility or coverage.
(4) The insurance carrier, applicant, or policy or contract holder may not waive the provisions of paragraph (3)(ii) of this subsection under any circumstances.
(d) The Commissioner may issue an order under §§ 4–113 and 4–114 of this article or §§ 27–501 and 27–505 of this title if the Commissioner finds a violation of this section.
Status: in_force · Read it on the official government site
Need a lawyer in Maryland?
Find a Maryland lawyer
About this page: Statute text is reproduced from official government publishers via the
Open US Law dataset
(Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine
(Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.